+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

South Korea Biopharma & Advanced Therapies Market - Product Thumbnail Image

South Korea Biopharma & Advanced Therapies Market

  • Report
  • October 2025
  • 98 Pages
  • South Korea
From
UK Cold Chain for Pharma & Biologics Market - Product Thumbnail Image

UK Cold Chain for Pharma & Biologics Market

  • Report
  • September 2025
  • 80 Pages
  • United Kingdom
From
Poland Biopharma Manufacturing & CDMO Market - Product Thumbnail Image

Poland Biopharma Manufacturing & CDMO Market

  • Report
  • September 2025
  • 91 Pages
  • Poland
From
Turkey Biopharma Contract Research (CRO) Market - Product Thumbnail Image

Turkey Biopharma Contract Research (CRO) Market

  • Report
  • September 2025
  • 84 Pages
  • Turkey
From
Germany Biotech Vaccines & Therapeutics Market - Product Thumbnail Image

Germany Biotech Vaccines & Therapeutics Market

  • Report
  • September 2025
  • 96 Pages
  • Germany
From
South America Cell Counting Market Outlook, 2030 - Product Thumbnail Image

South America Cell Counting Market Outlook, 2030

  • Report
  • June 2025
  • 80 Pages
From
South America Biosimilars Market Outlook, 2030 - Product Thumbnail Image

South America Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 80 Pages
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Bioprocessing Markets and Forecast, 2023 - Product Thumbnail Image

Bioprocessing Markets and Forecast, 2023

  • Report
  • August 2023
  • 66 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more